Autopsy report · NCT02153437
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
Cause of deathNo reason given
Life of this trial
- Registered 5 months before it started.
- Ran for about 2 years before it stopped.
- 7 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Bristol-Myers Squibb
- Sponsor type
- Industry
- Conditions
- Atrial Fibrillation
- Interventions
- BMS-919373; Sotalol; Placebo for BMS-919373
- Participants
- 7
- Sites
- 6
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.